Ghana’s Volta Region is poised for a major pharmaceutical and scientific breakthrough following a strategic engagement between Council of State Member Gabriel Tanko and Swiss pharmaceutical company Lagap SA.
Speaking at the Global Parliament of Mayors Annual Summit in Braga, Portugal, Mr. Tanko revealed that he, alongside his wife, Her Excellency Patricia Awoonor—popularly known as Mama Nyaxorladeakorla I of Anlo—used the global platform to attract key development partnerships for Ghana.
A standout moment from the summit was their engagement with Lagap SA in Bellinzona, Switzerland.
The pharmaceutical company, established in 1959, is known for high-quality medicinal products distributed to over 25 countries.
Their flagship products include Librocol (for heart conditions), Exfortan (metabolic health), d-Mannosa (urinary care), Apixan, Fosfolag, Sitalag, and Irona.
Mr. Tanko disclosed that discussions with Lagap SA management centered on establishing a scientific research centre in the Volta Region, with a long-term goal of building a full-scale pharmaceutical production plant.
This initiative aligns with the region’s growing reputation as a health and research hub, home to the prestigious University of Health and Allied Sciences (UHAS).
“We believe the Volta Region is ripe for such a partnership,” Mr. Tanko said. “Not only will this make essential medicines more accessible and affordable, it will also create sustainable jobs, support our young scientists, and energize the local pharmaceutical industry.”
The engagement culminated in the signing of a Memorandum of Understanding (MoU) between Mr. Tanko’s office and Lagap SA.
This agreement grants a framework to facilitate access to Lagap’s products in Ghana and lays the foundation for future collaborations in scientific research and drug manufacturing.
Her Excellency Patricia Awoonor, who also attended the summit as a traditional leader and development advocate, played a key role in the diplomatic and business discussions.
“This is a significant opportunity for our region and our country,” Mr. Tanko emphasized. “I remain committed to ensuring this partnership brings real and lasting impact to our people.”
The initiative marks a new chapter in local pharmaceutical development, signaling Ghana’s intent to reduce its dependence on imported drugs and foster long-term healthcare resilience.
